Finance

Lists
Why is 300841 up 2,09%?
Dive Deeper
300841:SHE
Chengdu Kanghua Biological Prdcts Co Ltd
CNÂ¥55,26
+2,09%
(+1,13) 1D
9 Okt., 15:04:49 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300841...
Open
CNÂ¥54,25
High
CNÂ¥55,55
Low
CNÂ¥52,71
Mkt. cap
7,18 mjd
Avg. vol.
4,04 m
Volume
3,43 m
Dividend
0,90%
Quarterly dividend
CNÂ¥0,13
Ex-dividend date
29 Mei 2026
P/E ratio
29,13
52-wk high
CNÂ¥86,50
52-wk low
CNÂ¥42,31
EPS
CNÂ¥1,90
Shares outstanding
129,95 m
No. of employees
550
Open
CNÂ¥54,25
High
CNÂ¥55,55
Low
CNÂ¥52,71
Mkt. cap
7,18 mjd
Avg. vol.
4,04 m
Volume
3,43 m
Dividend
0,90%
Quarterly dividend
CNÂ¥0,13
Ex-dividend date
29 Mei 2026
P/E ratio
29,13
52-wk high
CNÂ¥86,50
52-wk low
CNÂ¥42,31
EPS
CNÂ¥1,90
Shares outstanding
129,95 m
No. of employees
550
News stories
From web sources and news partners
About Chengdu Kanghua Biological Prdcts Co Ltd
CEO-
Employees550
Founded02 Apr. 2004
Headquarters-
Sector-
Websitekangh.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
356,14 m
324,94 m
172,45 m
365,90 m
Cost of goods sold
29,78 m
36,11 m
15,56 m
45,85 m
Cost of revenue
29,78 m
36,11 m
15,56 m
45,85 m
Research and development expenses
28,12 m
35,39 m
20,45 m
20,05 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
205,95 m
215,74 m
100,49 m
170,93 m
Operating expense
226,61 m
262,01 m
126,67 m
201,41 m
Total operating expenses
256,39 m
298,12 m
142,23 m
247,27 m
Operating income
99,75 m
26,82 m
30,22 m
118,63 m
Other non operating income
513,89 k
-518,72 k
-25,19 k
43,30 k
EBT including unusual items
96,16 m
38,09 m
29,54 m
129,34 m
EBT excluding unusual items
103,59 m
30,06 m
31,07 m
121,88 m
Income tax expense
21,57 m
7,30 m
2,18 m
15,55 m
Effective tax rate
22,43%
19,17%
7,38%
12,02%
Other operating expenses
1,45 m
4,16 m
3,95 m
3,33 m
Net income
74,59 m
30,79 m
27,36 m
113,79 m
Net profit margin
20,94%
9,47%
15,87%
31,10%
Earnings per share
-
-
-
-
Interest and investment income
4,20 m
4,53 m
1,23 m
3,24 m
Interest expense
-815,27 k
-822,31 k
-349,08 k
-
Net interest expenses
3,39 m
3,71 m
878,06 k
3,24 m
Depreciation and amortization charges
-
-
-
-
EBITDA
115,60 m
45,20 m
48,60 m
136,48 m
Gain or loss from assets sale
-8,91 k
8,91 k
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme